IP Library Granted Patent US 10,219,859
Granted Patent B2
US 10,219,859 · App. 15/094,830 · Granted Mar 5, 2019

Vacuum coagulation probes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,219,859
App. No.
15/094,830
Granted
Mar 5, 2019
Kind
B2
Abstract

Methods for using a surgical device integrating a suction mechanism with a coagulation mechanism for improving lesion creation capabilities. The device comprises an elongate member having an insulative covering attached about means for coagulating soft tissue. Openings through the covering expose regions of the coagulation-causing elements and are coupled to lumens in the elongate member which are routed to a vacuum source and a fluid source to passively transport fluid along the contacted soft tissue surface in order to push the maximum temperature deeper into tissue.

Claims (21)

1. A method for positioning a treatment device against a surface of tissue, where the treatment device having an opening exposing an electrode, the treatment device having a vacuum lumen and a fluid perfusion lumen both fluidly coupled to the opening, the method comprising:

advancing the treatment device to a surface of tissue;

positioning the opening against the surface of tissue;

drawing a vacuum in the vacuum lumen to reduce pressure in both the vacuum lumen and the opening causing the opening to form a fluid seal with the surface of the tissue, where formation of the seal causes a fluid flow through the fluid perfusion lumen across the opening and through the vacuum lumen, where breaking of the seal stops the fluid flow the fluid perfusion lumen; and

observing the fluid flow to confirm engagement between the electrode and the surface of tissue.

2. The method of claim 1 , where advancing the treatment device to the surface the soft tissue comprises advancing the treatment device to a liver, prostate, colon, esophagus, gastrointestinal region, and gynecological region.

3. The method of claim 1 , where advancing the treatment device to the surface of the soft tissue comprises advancing the treatment device during a procedure selected from the group consisting of an arthroscopic, laparoscopic, and other minimally invasive procedure.

4. The method of claim 1 , further comprising applying energy from the electrode to the surface of tissue.

5. The method of claim 4 , further comprising energizing the electrode only after observing the fluid flow.

6. The method of claim 5 , where energizing the electrode during the fluid flow to create the lesion in the surface of soft tissue comprises applying vibrational energy to the electrode to create a contiguous transmural lesion in atrial tissue.

7. The method of claim 5 , where energizing the electrode during the fluid flow to create the lesion in the surface of soft tissue comprises applying RF energy to the electrode to create a contiguous lesion in the surface of tissue.

8. The method of claim 7 , where creating the contiguous lesion comprises creating a series of contiguous lesions.

9. The method of claim 7 , where advancing the treatment device to the surface of tissue comprises advancing the treatment device to a plurality of regions to create a pattern of lesions in tissue.

10. The method of claim 7 , where the RF energy comprises a unipolar mode, and further comprising placing a reference element in electrical contact with tissue.

11. The method of claim 7 , where the RF energy comprises a bipolar mode.

12. The method of claim 1 , where the electrode has a length and conforms to the surface of soft tissue to create a curvilinear lesion.

13. The method of claim 1 , where the portion of the treatment device housing the electrode is pre-shapeable to assume a shape and where the lesion forms the shape.

14. The method of claim 1 , further comprising advancing a track adjacent to the surface and where advancing the treatment device to the surface comprises advancing the treatment device over the track.

15. The method of claim 14 , where the track comprises a device selected from the group consisting of a wire, a steerable catheter, a steerable guide-wire, a shaped tube, and a shaped mandrel.

16. The method of claim 1 , where the surface of tissue comprises a contoured surface and where the treatment device housing is conformable to the contoured surface.

17. The method of claim 16 , where the electrode is conformable to the contoured surface.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC; SENTREHEART LLC
Reel/Frame 066256/0797 →
SECURITY INTEREST Recorded Dec 18, 2018
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 047951/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2016
From: WHAYNE, JAMES G.; FLEISCHMAN, SIDNEY D.; ROGERS, EARL W.
To: NCONTACT SURGICAL, INC.
Reel/Frame 039216/0179 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2016
From: NCONTACT SURGICAL, LLC
To: ATRICURE, INC.
Reel/Frame 039216/0239 →